| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 162011-90-7 | 羅非昔布; 4-[4-(甲磺�；�)苯基]-3-苯基-2(5)H-呋喃酮 | Rofecoxib; Vioxx; 4-[4-(Methylsulfonyl)phenyl]-3-phenylfuran-2(5H)-one |  | C17H14O4S | 詳情 | 供應(yīng)商 |
| 169590-42-5 | 塞來西布; 塞內(nèi)昔布; 賽利克西; 4-[5-(4-甲基苯基)-3-(三氟甲基)吡挫-1-基]苯磺酰胺 | Celecoxib; 4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide |  | C17H14F3N3O2S | 詳情 | 供應(yīng)商 |
| 189954-96-9 | 非羅考昔; 3-(環(huán)丙基甲氧基)-5,5-二甲基-4-[4-(甲基磺酰基)苯基]-2(5H)-呋喃酮 | Firocoxib; 3-(Cyclopropylmethoxy)-5,5-dimethyl-4-[4-(methylsulfonyl)phenyl]-2(5H)-furanone |  | C17H20O5S | 詳情 | 供應(yīng)商 |
| 202409-33-4 | 依托考昔; 5-氯-2-(6-甲基吡啶-3-基)-3-(4-甲基磺酰苯基)吡啶 | Etoricoxib; 5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine |  | C18H15ClN2O2S | 詳情 | 供應(yīng)商 |
| 220991-20-8 | Benzeneacetic acid,2-[(2-chloro-6-fluorophenyl)amino]-5-methyl-; 2-[(2-Chloro-6-fluorophenyl)amino]-5-methylbenzeneaceticacid; 2-[2-(2-Chloro-6-fluorophenylamino)-5-methylphenyl]acetic acid; CGS35189; COX 189; Lumiracoxib; Prexige |  | C15H13ClFNO2 | 詳情 | 供應(yīng)商 | |
| 180200-68-4 | Benzenesulfonamide,4-(4-cyclohexyl-2-methyl-5-oxazolyl)-2-fluoro-; 4-(4-Cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide; JTE 522; JTP 19605; RWJ 57504; Tilmacoxib |  | C16H19FN2O3S | 詳情 | 供應(yīng)商 | |
| 169590-41-4 | Benzenesulfonamide,4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]-; 4-[5-(3-Fluoro-4-methoxyphenyl)-3-(difluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide; Deracoxib; Deram; Deramaxx; SC 046; SC 46; SC 59046 |  | C17H14F3N3O3S | 詳情 | 供應(yīng)商 | |
| 265114-23-6 | Benzenesulfonamide,4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)-1H-imidazol-1-yl]-; 4-[4-Chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]benzenesulfonamide; Cimicoxib; UR 8880 |  | C16H13ClFN3O3S | 詳情 | 供應(yīng)商 | |
| 220991-32-2 | Benzeneacetic acid,5-ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]-; CGS 34975; Robenacoxib |  | C16H13F4NO2 | 詳情 | 供應(yīng)商 | |
| 198470-84-7 | 帕瑞昔布; 帕瑞考昔 | Parecoxib; dynastat; rayzon; SC-69124 |  | C19H18N2O4S | 詳情 | 供應(yīng)商 |
| 198470-85-8 | Propanamide,N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-, sodium salt (1:1); Propanamide,N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-, sodium salt (9CI); Dynastat; Parecoxib sodium; Rayzon; SC 69124A |  | C19H18N2O4S.Na | 詳情 | 供應(yīng)商 | |
| 170571-00-3 | HYDROXYMETHYL CELEcoxib; HYDROXYMETHYL CELEcoxib; Hydroxy Celecoxib |  | C18H16F3N3O3S | 詳情 | 供應(yīng)商 | |
| 697287-17-5 | Lumiracoxib Acyl--D-glucuronide; 1-[2-[(2-Chloro-6-fluorophenyl)amino]-5-methylbenzeneacetate] -D-Glucopyranuronic Acid; Lumiracoxib Acyl--D-glucuronide |  | C21H21ClFNO9- | 詳情 | 供應(yīng)商 | |
| 181695-72-7 | 代他考昔 | VALDEcoxib; 4-(5-METHYL-3-PHENYL-4-ISOXAZOLYL)BENZENESULFONAMIDE; AKOS 92130; BEXTRA; VALDEcoxib; BEXTRA(VALDEcoxib); Bextra, 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenefulfonamide; 4-(5-methyl-3-phenyl-oxazol-4-yl)benzenesulfonamide; Bextra, 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide |  | C16H14N2O3S | 詳情 | 供應(yīng)商 |